RecruitingNot ApplicableNCT07798063

Effectiveness of Solution-Focused Therapy for Generalized Anxiety Disorder in Emerging Adults


Sponsor

International Islamic University, Islamabad

Enrollment

50 participants

Start Date

Jan 5, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study will evaluate whether Solution-Focused Therapy (SFT) helps reduce symptoms of Generalized Anxiety Disorder (GAD) in emerging adults in Pakistan. Participants will first be screened to identify those with mild to moderate levels of GAD. Eligible participants will be randomly assigned to receive either SFT or be placed on a waitlist. The researcher will measure changes in anxiety symptoms before and after the intervention to determine whether SFT is effective for emerging adults with GAD in Pakistan.


Eligibility

Min Age: 18 YearsMax Age: 29 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Solution-Focused Therapy for people with generalized anxiety disorder (gad). The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 29 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALSolution-Focused Therapy

Participants in intervention group will receive Solution-Focused Therapy. The program includes approximately 6-8 individual sessions (45-60 minutes) covering goal-setting, exception-finding, scaling questions, the miracle question, identification of existing strengths and resources, and construction of solution-focused action steps.


Locations(1)

International Islamic University Islamabad (IIUI)

Islamabad, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07798063


Related Trials